Business Times DC
SEE OTHER BRANDS

The latest business and economy news from Washington, D.C.

Business Times DC: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Business Times DC.

Press releases published on April 28, 2025

FTI Consulting Enhances Private Equity Expertise with Addition of Strategy and Transformation Expert Josh Harris

FTI Consulting Enhances Private Equity Expertise with Addition of Strategy and Transformation Expert Josh Harris

WASHINGTON, April 28, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Josh Harris as a Senior Managing Director in the Private Equity practice within the firm’s Corporate Finance …

Guardforce AI Reports Full-Year 2024 Financial Results and Provides Business Update

Guardforce AI Reports Full-Year 2024 Financial Results and Provides Business Update

Gross profit increased 16.1% in 2024 compared to 2023 Building a robust AI technology foundation to drive solution development in travel and retail Guardforce AI management to host conference call today at 8:30 AM ET NEW YORK, April 28, 2025 (GLOBE …

Embecta to host Analyst and Investor Day on May 22, 2025

Embecta to host Analyst and Investor Day on May 22, 2025

PARSIPPANY, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will hold an Analyst and Investor Day on May 22, 2025, from 9:00 a.m. to 12:30 p.m. in …

Veri Medtech (VRHI) Retains PCAOB Auditor

Veri Medtech (VRHI) Retains PCAOB Auditor

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- Veri Medtech Holdings, Inc. (OTC Markets: (“VRHI”) ("Veri Medtech") announced today that it has retained Salberg …

Tornado Infrastructure Equipment Reports Record 2024 Results

Tornado Infrastructure Equipment Reports Record 2024 Results

CALGARY, Alberta, April 28, 2025 (GLOBE NEWSWIRE) -- Tornado Infrastructure Equipment Ltd. (“Tornado” or the “Company”) (TSX-V: TGH; OTCQX: TGHLF) today reported its audited consolidated financial results for the year ended December 31, 2024, with …

FitLife Brands Announces Board Transition

FitLife Brands Announces Board Transition

Omaha, NE, April 28, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife” or the “Company”) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, announced today the resignation of Todd Ordal as a …

Nano Dimension to Host 2024 Financial Results and 2025 Outlook Conference Call

Nano Dimension to Host 2024 Financial Results and 2025 Outlook Conference Call

Call to Be Held Wednesday, April 30 at 4:30 PM EST Waltham, Massachusetts, April 28, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leader in Digital Manufacturing solutions, today announced it will host …

Exodus Movement, Inc. to Announce First Quarter 2025 Results on May 12, 2025

Exodus Movement, Inc. to Announce First Quarter 2025 Results on May 12, 2025

OMAHA, Neb., April 28, 2025 (GLOBE NEWSWIRE) -- Exodus Movement, Inc. (NYSE American: EXOD) ("Exodus"), a leading self-custodial cryptocurrency platform, today announced that it will release its first quarter financial results on Monday, May 12, 2025, …

Montage Gold Announces Graduation to the Toronto Stock Exchange

Montage Gold Announces Graduation to the Toronto Stock Exchange

VANCOUVER, British Columbia, April 28, 2025 (GLOBE NEWSWIRE) -- Montage Gold Corp. (“Montage” or the “Company”) (TSXV: MAU, OTCQX: MAUTF) is pleased to announce that it has received final approval from the Toronto Stock Exchange ("TSX") for the listing of …

Crescent Biopharma Appoints David Lubner to Board of Directors

Crescent Biopharma Appoints David Lubner to Board of Directors

Industry Veteran Brings 30 Years of Experience in Finance, Strategy and Operations WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent”), a private biotechnology company developing novel precision-engineered molecules …

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

Overall survival and clinical benefit in Phase 2 continue to outperform historical benchmarks, including very heavily pretreated patients Clinical benefit observed in 83% of evaluable patient sub-group treated with the phase 3 formulation Improved new Bria …

BitMart Shines at TOKEN2049 Dubai: A Pinnacle Moment of Innovation and Global Impact

BitMart Shines at TOKEN2049 Dubai: A Pinnacle Moment of Innovation and Global Impact

Dubai, UAE, April 28, 2025 (GLOBE NEWSWIRE) -- From April 30 to May 1, 2025, the annual premier event in the crypto and blockchain space, TOKEN2049, will make its grand debut at Madinat Jumeirah in Dubai. As a Platinum Sponsor, BitMart will showcase its …

ElevateBio Announces Transition of David Hallal to Executive Chairman of the Board of Directors

ElevateBio Announces Transition of David Hallal to Executive Chairman of the Board of Directors

WALTHAM, Mass., April 28, 2025 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven company focused on powering the creation of life-transforming genetic medicines, announced that David Hallal will transition from Chairman and CEO to Executive Chairman of …

NANO Nuclear Announces Full Dismissal of Nevada Lawsuit

NANO Nuclear Announces Full Dismissal of Nevada Lawsuit

New York, N.Y., April 28, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that on …

EBC Financial Group Deepens Commitment to United to Beat Malaria with Renewed Global Partnership and First-Ever 5K Run Sponsorship

EBC Financial Group Deepens Commitment to United to Beat Malaria with Renewed Global Partnership and First-Ever 5K Run Sponsorship

WASHINGTON, April 28, 2025 (GLOBE NEWSWIRE) -- As the world marks World Malaria Day 2025 under the theme “Malaria Ends With Us: Reinvest, Reimagine, Reignite,” EBC Financial Group (EBC) is renewing its global partnership with the United Nations Foundation’ …

Gilat to Participate in the 20th Annual Needham Technology, Media & Consumer Conference on May 13th, 2025

Gilat to Participate in the 20th Annual Needham Technology, Media & Consumer Conference on May 13th, 2025

PETAH TIKVA, Israel, April 28, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, today announced management’s participation in the 20th Annual …

Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting

Avacta Therapeutics Presents Data from Lead pre|CISION® Candidate FAP-Dox (AVA6000) at the 2025 AACR Annual Meeting

Compelling Phase 1 safety and efficacy data for FAP-Dox (AVA6000) with preliminary evidence of efficacy in salivary gland cancers and no severe cardiac toxicity Progression free survival (PFS) data to date represents a near doubling of the benchmarking …

BPGbio CEO Dr. Niven R. Narain Named to The Medicine Maker Power List 2025

BPGbio CEO Dr. Niven R. Narain Named to The Medicine Maker Power List 2025

BOSTON, April 28, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered clinical-stage biopharma company, today announced that President and CEO Niven R. Narain, Ph.D. has been named to The Medicine Maker’s Power List 2025. The annual list …

Hudbay’s Eugene Lei wins Globe and Mail’s Report on Business 2025 Best Executive Award

Hudbay’s Eugene Lei wins Globe and Mail’s Report on Business 2025 Best Executive Award

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) is pleased to announce that Eugene Lei, Chief Financial Officer at Hudbay, has been recognized as a winner of the Globe and Mail’s Report on …

EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease

EYLEA HD® (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Continued Safety and Efficacy and Highlight Early Real-World Outcomes for Patients with Serious Retinal Disease

Initial real-world data from nearly 40,000 EYLEA HD patients will provide early insights on effectiveness of EYLEA HD in everyday clinical practice New indirect comparisons will evaluate EYLEA HD and faricimab on measures of efficacy, dosing frequency and …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service